Delivery Order SPE2DR25D3013-SPE2DR26F7C5L
Award Date 3/26/26
Potential Completion Date 3/27/26
Potential Value $5.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $9,379.16 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides global pharmaceutical support across multiple therapeutic domains to military healthcare programs. Place of performance is Conshohocken, PA. The order was awarded on a firm...
- The Defense Logistics Agency issued a $9,376.74 delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued up to $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price...
- The Defense Logistics Agency issued a $9,115.23 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product. The order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical support vehicle running through December 2026 that enables supply of brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to military...
- The Defense Logistics Agency issued a $29,330.94 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a single-award indefinite delivery contract valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies to military healthcare...
- The Defense Logistics Agency issued a $50,054.44 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price, no set-aside, and an ultimate...
- The Defense Logistics Agency issued a $5,124.30 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for ACTEMRA 400 mg/20 mL vial pharmaceutical supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which serves as a global pharmaceutical support vehicle enabling supply of medications and medical commodities to military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product, with a ceiling value of $15,746.54. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides global pharmaceutical support to military healthcare systems. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price...
- The Defense Logistics Agency issued a $5,237.78 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical supply. The order is placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a $20,155.32 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for ACTEMRA 400 mg/20 ml vials. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate...
- The Defense Logistics Agency issued a $9,331.28 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical product. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure and has an ultimate completion date of March 3, 2026. No set-aside was used. The delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F7C5LDelivery Order
The Defense Logistics Agency issued a $5,059.92 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product. The order is placed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides global pharmaceutical and medical supply support to military healthcare programs. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with an ultimate completion date of March 27, 2026. No set-aside was applied.
Generated 6/25/26, 10:24 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 3/25/26 |